Medtronic plc - 美敦力
"Engineering the extraordinary"
Global medical device leader based in Ireland, offering the Hugo RAS surgical robot, neurostimulation systems, and minimally invasive therapies.
Medtronic plc is one of the world's largest medical technology companies, founded in 1949 by Earl Bakken and Palmer Hermundslie in Minneapolis, Minnesota, and legally domiciled in Dublin, Ireland since 2015 following the acquisition of Covidien. The company operates in over 150 countries with more than 90,000 employees. In robotics, Medtronic offers the Hugo RAS (Robotic-Assisted Surgery) system — a modular, multi-quadrant soft-tissue surgical platform designed to compete with da Vinci and other laparoscopic robotic systems.
Medtronic also leads in neuromodulation and brain stimulation devices, including deep brain stimulation (DBS) systems for Parkinson's disease and chronic pain. Its Minneapolis operational headquarters drives R&D across cardiac, spine, diabetes, and surgical robotics divisions.
Primary type & automation activities this supplier delivers:
Hugo RAS System
Modular multi-quadrant robotic-assisted surgery platform for soft-tissue minimally invasive procedures.
Percept PC Deep Brain Stimulation System
Implantable neurostimulator for deep brain stimulation therapy in Parkinson's disease, tremor, and dystonia.
Contact Medtronic plc
WEBSITE
https://news.medtronic.comPHONE
-1786HEADQUARTERS
United States
Company Facts
Founded
1949
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-
Medtronic Unveils AI Compute Platform Touch Surgery Aide for Operating Rooms
Medtronic PLC recently introduced its AI-powered compute platform, Touch Surgery Aide, designed for the operating room. This platform enhances the Touch Surgery Ecosystem by connecting pre-operative planning, intra-operative support, and post-operative insights, thereby simplifying surgical workflows and expanding access beyond individual operating rooms. The significance of Touch Surgery Aide lies in its ability to provide real-time AI-driven support during surgeries, offering actionable insights that enhance clinical decision-making. According to Jim Peichel, Medtronic's chief technology officer, this platform represents a fundamental evolution in surgical support, enabling teams to work more efficiently and effectively. Touch Surgery Aide will be showcased at the Society of Robotic Surgery (SRS) 2026 Annual Meeting in Hollywood, Florida. The platform incorporates NVIDIA's advanced computing technologies and is designed to support future expansion into laparoscopic surgery, with the Instrument Exit Point (IEP) application already receiving FDA clearance for use with the Hugo robotic-assisted surgery system.
Artificial Intelligence Artificial Intelligence / Cognition Design / Development Healthcare Robotics Markets / Industries News
